Lv713
3420 积分 2024-06-18 加入
Scalable Synthesis of Lunresertib, a Selective PKMYT1 Inhibitor
1天前
已完结
Discovery of an Orally Bioavailable and Selective PKMYT1 Inhibitor, RP-6306
1天前
已完结
Myt1: A Membrane-Associated Inhibitory Kinase That Phosphorylates Cdc2 on Both Threonine-14 and Tyrosine-15
1天前
已完结
Debio 0123, a WEE1 kinase inhibitor: Phase 1 results from dose escalation in patients with advanced solid tumors
4天前
已完结
From KRAS G12D to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug Design
12天前
已完结
Current developments in PI3K-based anticancer agents: Designing strategies, biological activity, selectivity, structure-activity correlation, and docking insight
18天前
已完结
20 years since the approval of first EGFR-TKI, gefitinib: Insight and foresight
19天前
已完结
The role of convection-enhanced delivery in the treatment of GBM
23天前
已完结
Pancreatic cancer
1个月前
已完结
Mapping the molecular landscape of glioblastoma: Pathogenesis, therapeutic targets and bioactive interventions
1个月前
已完结
皖公网安备34019202002308
